MyChesCo on MSN10mon
AstraZeneca Expands Savings Program for Respiratory Medicines, Aiming to Ease Patient Costs
The updated savings scheme will encompass several key products in AstraZeneca’s US inhaled respiratory medicines lineup, ...
pharmaphorum7y
AstraZeneca to pay up to $2 billion for Almirall respiratory franchise
AstraZeneca has a heritage in respiratory medicine, but has not produced any new products in the field for some time. Its existing asthma and COPD franchise is made up of Pulmicort (which earned $ ...
FiercePharma2y
AstraZeneca's vision for the future of respiratory care
AstraZeneca's Maria Belvisi explores innovative approaches in respiratory medicine, from AI-driven trials to next-gen therapeutics. Following a successful visit to COP 28 in Dubai, AstraZeneca’s ...
pharmaphorum10d
AstraZeneca, Honeywell partner to address climate change with new inhaler tech
UK-based global pharma company AstraZeneca and US consumer products company Honeywell have ... “The work we are doing with AstraZeneca developing a respiratory inhaler, with a new near-zero ...
Warc4y
AstraZeneca Respiratory: Breathless Moments
Today, 70% of African asthma and COPD sufferers are undiagnosed and the WHO forecasts a 20% increase in respiratory related deaths in the next 10 years. AstraZeneca asked us to create awareness and ...
The Scientist8y
MRC Technology and AstraZeneca call for epigenetic targets in respiratory disease
AstraZeneca and MRCT are particularly interested to hear from researchers studying epigenetic mechanisms involved in respiratory diseases such as ... in life science research and clinical diagnostics ...